Eosinophil-to-Neutrophil Ratio Predicts Poor Prognosis of Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis

Background and Purpose: The eosinophil-to-neutrophil ratio (ENR) was recently reported as a novel inflammatory marker in acute ischemic stroke (AIS). However, few studies reported the predictive value of ENR in AIS patients, especially for those with intravenous thrombolysis.Methods: Two hundred six...

Full description

Bibliographic Details
Main Authors: Haoye Cai, Honghao Huang, Chenguang Yang, Junli Ren, Jianing Wang, Beibei Gao, Wenjing Pan, Fangyue Sun, Xinbo Zhou, Tian Zeng, Jingyu Hu, Yilin Chen, Shunkai Zhang, Guangyong Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.665827/full
_version_ 1818644283406680064
author Haoye Cai
Honghao Huang
Honghao Huang
Chenguang Yang
Chenguang Yang
Junli Ren
Junli Ren
Jianing Wang
Jianing Wang
Beibei Gao
Wenjing Pan
Wenjing Pan
Fangyue Sun
Fangyue Sun
Xinbo Zhou
Xinbo Zhou
Tian Zeng
Tian Zeng
Jingyu Hu
Jingyu Hu
Yilin Chen
Yilin Chen
Shunkai Zhang
Guangyong Chen
author_facet Haoye Cai
Honghao Huang
Honghao Huang
Chenguang Yang
Chenguang Yang
Junli Ren
Junli Ren
Jianing Wang
Jianing Wang
Beibei Gao
Wenjing Pan
Wenjing Pan
Fangyue Sun
Fangyue Sun
Xinbo Zhou
Xinbo Zhou
Tian Zeng
Tian Zeng
Jingyu Hu
Jingyu Hu
Yilin Chen
Yilin Chen
Shunkai Zhang
Guangyong Chen
author_sort Haoye Cai
collection DOAJ
description Background and Purpose: The eosinophil-to-neutrophil ratio (ENR) was recently reported as a novel inflammatory marker in acute ischemic stroke (AIS). However, few studies reported the predictive value of ENR in AIS patients, especially for those with intravenous thrombolysis.Methods: Two hundred sixty-six AIS patients receiving intravenous thrombolysis were retrospectively recruited in this study and followed up for 3 months and 1 year. The Modified Rankin Scale (mRS) and the time of death were recorded. Poor outcome was defined as mRS 3–6. After excluding patients who were lost to follow-up, the remaining 250 patients were included in the 3-month prognosis analysis and the remaining 223 patients were included in the 1-year prognosis analysis.Results: ENR levels in the patients were lower than those in the healthy controls. The optimal cutoff values for the ability of ENR × 102 to predict 3-month poor outcome were 0.74 with 67.8% sensitivity and 77.3% specificity. Patients with ENR × 102 ≥ 0.74 have a lower baseline National Institutes of Health Stroke Scale (NIHSS) score (median: 7 vs. 11, p < 0.001). After multivariate adjustment, patients with ENR × 102 ≥ 0.74 were more likely to come to a better 3-month outcome (OR = 0.163; 95% CI, 0.076–0.348, p < 0.001). At the 1-year follow-up, the patients with ENR × 102 ≥ 0.74 showed a lower risk of mortality (HR = 0.314; 95% CI, 0.135–0.731; p = 0.007).Conclusions: A lower ENR is independently associated with a 3-month poor outcome and a 3-month and 1-year mortality in AIS patients treated with intravenous thrombolysis.
first_indexed 2024-12-17T00:12:23Z
format Article
id doaj.art-2c4180e75eea485883b0bd3ce798a5a7
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-12-17T00:12:23Z
publishDate 2021-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-2c4180e75eea485883b0bd3ce798a5a72022-12-21T22:10:47ZengFrontiers Media S.A.Frontiers in Neurology1664-22952021-07-011210.3389/fneur.2021.665827665827Eosinophil-to-Neutrophil Ratio Predicts Poor Prognosis of Acute Ischemic Stroke Patients Treated With Intravenous ThrombolysisHaoye Cai0Honghao Huang1Honghao Huang2Chenguang Yang3Chenguang Yang4Junli Ren5Junli Ren6Jianing Wang7Jianing Wang8Beibei Gao9Wenjing Pan10Wenjing Pan11Fangyue Sun12Fangyue Sun13Xinbo Zhou14Xinbo Zhou15Tian Zeng16Tian Zeng17Jingyu Hu18Jingyu Hu19Yilin Chen20Yilin Chen21Shunkai Zhang22Guangyong Chen23Department of Rehabilitation Medicine, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaDepartment of Neurology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaSchool of the First Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, ChinaDepartment of Neurology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaSchool of the First Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, ChinaDepartment of Neurology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaSchool of the First Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, ChinaDepartment of Neurology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaSchool of the First Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, ChinaDepartment of Internal Medicine, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaDepartment of Neurology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaSchool of the First Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, ChinaDepartment of Neurology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaSchool of the First Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, ChinaDepartment of Neurology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaSchool of the First Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, ChinaDepartment of Neurology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaSchool of the First Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, ChinaDepartment of Neurology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaSchool of the First Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, ChinaDepartment of Neurology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaSchool of the First Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, ChinaDepartment of Neurology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaDepartment of Neurology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaBackground and Purpose: The eosinophil-to-neutrophil ratio (ENR) was recently reported as a novel inflammatory marker in acute ischemic stroke (AIS). However, few studies reported the predictive value of ENR in AIS patients, especially for those with intravenous thrombolysis.Methods: Two hundred sixty-six AIS patients receiving intravenous thrombolysis were retrospectively recruited in this study and followed up for 3 months and 1 year. The Modified Rankin Scale (mRS) and the time of death were recorded. Poor outcome was defined as mRS 3–6. After excluding patients who were lost to follow-up, the remaining 250 patients were included in the 3-month prognosis analysis and the remaining 223 patients were included in the 1-year prognosis analysis.Results: ENR levels in the patients were lower than those in the healthy controls. The optimal cutoff values for the ability of ENR × 102 to predict 3-month poor outcome were 0.74 with 67.8% sensitivity and 77.3% specificity. Patients with ENR × 102 ≥ 0.74 have a lower baseline National Institutes of Health Stroke Scale (NIHSS) score (median: 7 vs. 11, p < 0.001). After multivariate adjustment, patients with ENR × 102 ≥ 0.74 were more likely to come to a better 3-month outcome (OR = 0.163; 95% CI, 0.076–0.348, p < 0.001). At the 1-year follow-up, the patients with ENR × 102 ≥ 0.74 showed a lower risk of mortality (HR = 0.314; 95% CI, 0.135–0.731; p = 0.007).Conclusions: A lower ENR is independently associated with a 3-month poor outcome and a 3-month and 1-year mortality in AIS patients treated with intravenous thrombolysis.https://www.frontiersin.org/articles/10.3389/fneur.2021.665827/fullischemic strokeinflammationprognosisthrombolysiseosinophil-to-neutrophil ratio
spellingShingle Haoye Cai
Honghao Huang
Honghao Huang
Chenguang Yang
Chenguang Yang
Junli Ren
Junli Ren
Jianing Wang
Jianing Wang
Beibei Gao
Wenjing Pan
Wenjing Pan
Fangyue Sun
Fangyue Sun
Xinbo Zhou
Xinbo Zhou
Tian Zeng
Tian Zeng
Jingyu Hu
Jingyu Hu
Yilin Chen
Yilin Chen
Shunkai Zhang
Guangyong Chen
Eosinophil-to-Neutrophil Ratio Predicts Poor Prognosis of Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis
Frontiers in Neurology
ischemic stroke
inflammation
prognosis
thrombolysis
eosinophil-to-neutrophil ratio
title Eosinophil-to-Neutrophil Ratio Predicts Poor Prognosis of Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis
title_full Eosinophil-to-Neutrophil Ratio Predicts Poor Prognosis of Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis
title_fullStr Eosinophil-to-Neutrophil Ratio Predicts Poor Prognosis of Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis
title_full_unstemmed Eosinophil-to-Neutrophil Ratio Predicts Poor Prognosis of Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis
title_short Eosinophil-to-Neutrophil Ratio Predicts Poor Prognosis of Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis
title_sort eosinophil to neutrophil ratio predicts poor prognosis of acute ischemic stroke patients treated with intravenous thrombolysis
topic ischemic stroke
inflammation
prognosis
thrombolysis
eosinophil-to-neutrophil ratio
url https://www.frontiersin.org/articles/10.3389/fneur.2021.665827/full
work_keys_str_mv AT haoyecai eosinophiltoneutrophilratiopredictspoorprognosisofacuteischemicstrokepatientstreatedwithintravenousthrombolysis
AT honghaohuang eosinophiltoneutrophilratiopredictspoorprognosisofacuteischemicstrokepatientstreatedwithintravenousthrombolysis
AT honghaohuang eosinophiltoneutrophilratiopredictspoorprognosisofacuteischemicstrokepatientstreatedwithintravenousthrombolysis
AT chenguangyang eosinophiltoneutrophilratiopredictspoorprognosisofacuteischemicstrokepatientstreatedwithintravenousthrombolysis
AT chenguangyang eosinophiltoneutrophilratiopredictspoorprognosisofacuteischemicstrokepatientstreatedwithintravenousthrombolysis
AT junliren eosinophiltoneutrophilratiopredictspoorprognosisofacuteischemicstrokepatientstreatedwithintravenousthrombolysis
AT junliren eosinophiltoneutrophilratiopredictspoorprognosisofacuteischemicstrokepatientstreatedwithintravenousthrombolysis
AT jianingwang eosinophiltoneutrophilratiopredictspoorprognosisofacuteischemicstrokepatientstreatedwithintravenousthrombolysis
AT jianingwang eosinophiltoneutrophilratiopredictspoorprognosisofacuteischemicstrokepatientstreatedwithintravenousthrombolysis
AT beibeigao eosinophiltoneutrophilratiopredictspoorprognosisofacuteischemicstrokepatientstreatedwithintravenousthrombolysis
AT wenjingpan eosinophiltoneutrophilratiopredictspoorprognosisofacuteischemicstrokepatientstreatedwithintravenousthrombolysis
AT wenjingpan eosinophiltoneutrophilratiopredictspoorprognosisofacuteischemicstrokepatientstreatedwithintravenousthrombolysis
AT fangyuesun eosinophiltoneutrophilratiopredictspoorprognosisofacuteischemicstrokepatientstreatedwithintravenousthrombolysis
AT fangyuesun eosinophiltoneutrophilratiopredictspoorprognosisofacuteischemicstrokepatientstreatedwithintravenousthrombolysis
AT xinbozhou eosinophiltoneutrophilratiopredictspoorprognosisofacuteischemicstrokepatientstreatedwithintravenousthrombolysis
AT xinbozhou eosinophiltoneutrophilratiopredictspoorprognosisofacuteischemicstrokepatientstreatedwithintravenousthrombolysis
AT tianzeng eosinophiltoneutrophilratiopredictspoorprognosisofacuteischemicstrokepatientstreatedwithintravenousthrombolysis
AT tianzeng eosinophiltoneutrophilratiopredictspoorprognosisofacuteischemicstrokepatientstreatedwithintravenousthrombolysis
AT jingyuhu eosinophiltoneutrophilratiopredictspoorprognosisofacuteischemicstrokepatientstreatedwithintravenousthrombolysis
AT jingyuhu eosinophiltoneutrophilratiopredictspoorprognosisofacuteischemicstrokepatientstreatedwithintravenousthrombolysis
AT yilinchen eosinophiltoneutrophilratiopredictspoorprognosisofacuteischemicstrokepatientstreatedwithintravenousthrombolysis
AT yilinchen eosinophiltoneutrophilratiopredictspoorprognosisofacuteischemicstrokepatientstreatedwithintravenousthrombolysis
AT shunkaizhang eosinophiltoneutrophilratiopredictspoorprognosisofacuteischemicstrokepatientstreatedwithintravenousthrombolysis
AT guangyongchen eosinophiltoneutrophilratiopredictspoorprognosisofacuteischemicstrokepatientstreatedwithintravenousthrombolysis